The biotechnology company's antibody screening technology will benefit from the FDA's emergency authorization of plasma for COVID-19 patients.
News
- XBiotech, AstraZeneca rise; Churchill Downs, Gilead fall
- Approval of a coronavirus vaccine would be just the beginning – huge production challenges could ...
The number of U.S. biotech and pharmaceutical companies involved in vaccines development and production has fallen from 26 in 1967 to just five in ...
- Japan's Takeda sells drugs subsidiary to US Blackstone fund
Takeda, which acquired international biotech company Shire in 2019, has recently been selling off what it sees as its other non-core assets, including ...
- The Latest: Children's mental health a concern amid pandemic
The vaccine is produced by ReiThera, a biotech company near Rome. Half the participants are younger than 55 and half are older than 65.
- JBSA-Fort Sam Houston soldiers help South Texas Blood and Tissue Center with convalescent ...
SAN ANTONIO – As requests for COVID-19 convalescent plasma spiked in late spring and early summer, the South Texas Blood and Tissue Center ...